Engine Biosciences to raise additional funding next year
Singapore
A BIOTECH startup that only this year raised what is believed to be the largest round of seed funding in South-east Asia has plans to raise additional funding as early as next year, The Business Times has learnt.
Engine Biosciences, a Singapore-based company that has built an artificial intelligence (AI) and genomics network biomedicine platform to enable faster and more effective drug discovery, in January said that it had snagged US$10 million in seed funding, one of the largest rounds in Asia in the tech and biotech industries.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Technology
Garmin’s Q1 results beat on strong demand for fitness, auto products
Foxconn’s musical chairs sound like punk rock
US sets up board to advise on safe, secure use of AI
Regulate AI? How US, EU and China are going about It
Meta’s results are best viewed through rose-tinted AI glasses
'Harvesting data': Latin American AI startups transform farming